Multicentre cross-over study of aminoglutethimide and trilostane in advanced postmenopausal breast cancer
Identifieur interne : 000936 ( France/Analysis ); précédent : 000935; suivant : 000937Multicentre cross-over study of aminoglutethimide and trilostane in advanced postmenopausal breast cancer
Auteurs : C. J. Williams [Royaume-Uni] ; V. L. Barley [Royaume-Uni] ; G. R. Blackledge [Royaume-Uni] ; C. G. Rowland [Royaume-Uni] ; C. J. Tyrrell [Royaume-Uni] ; F. Bachelot [France] ; A. Dermaille [France] ; P. Fargeot [France] ; M. Namer [France] ; J. Pouillart [France] ; D. Serin [France]Source :
- Clinical Oncology [ 0936-6555 ] ; 1995.
English descriptors
- KwdEn :
Abstract
Abstract: Trilostane and aminoglutethimide, both given with a physiological replacement dose of hydrocortisone, were randomly allocated to 112 eligible patients with postmenopausal advanced breast cancer. Following treatment failure on either drug the patient continued with the other, if they were in a suitable clinical condition. Sixty-three patients initially received trilostane, of whom 33 subsequently received aminoglutethimide; 49 patients initially had aminoglutethimide and 14 of these then received trilostane. Both groups of patients were comparable in all respects. There was no difference in the response rate to either drug or in the average time to disease progression for the two drugs. Of the 47 patients who received both drugs, nine (19%) showed a response to both, indicating no cross-resistance. Side effects were seen to both drugs in approximately half the patients; these were mainly gastrointestinal symptoms with trilostane and rashes and drowsiness with aminoglutethimide. There was no evidence of cross-over patient susceptibility to side effects.
Url:
DOI: 10.1016/S0936-6555(05)80807-6
Affiliations:
- France, Royaume-Uni
- Angleterre, Bourgogne, Bourgogne-Franche-Comté, Hauts-de-France, Midlands de l'Ouest, Nord-Pas-de-Calais, Provence-Alpes-Côte d'Azur, Île-de-France
- Avignon, Birmingham, Dijon, Lille, Nice, Paris
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 005831
- to stream Istex, to step Curation: 005831
- to stream Istex, to step Checkpoint: 004811
- to stream Main, to step Merge: 00CE70
- to stream Main, to step Curation: 00C554
- to stream Main, to step Exploration: 00C554
- to stream France, to step Extraction: 000936
Links to Exploration step
ISTEX:BBAD81F85C00A1390B8FEF52A86D2F282DFFBCDFLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Multicentre cross-over study of aminoglutethimide and trilostane in advanced postmenopausal breast cancer</title><author><name sortKey="Williams, C J" sort="Williams, C J" uniqKey="Williams C" first="C. J." last="Williams">C. J. Williams</name></author><author><name sortKey="Barley, V L" sort="Barley, V L" uniqKey="Barley V" first="V. L." last="Barley">V. L. Barley</name></author><author><name sortKey="Blackledge, G R" sort="Blackledge, G R" uniqKey="Blackledge G" first="G. R." last="Blackledge">G. R. Blackledge</name></author><author><name sortKey="Rowland, C G" sort="Rowland, C G" uniqKey="Rowland C" first="C. G." last="Rowland">C. G. Rowland</name></author><author><name sortKey="Tyrrell, C J" sort="Tyrrell, C J" uniqKey="Tyrrell C" first="C. J." last="Tyrrell">C. J. Tyrrell</name></author><author><name sortKey="Bachelot, F" sort="Bachelot, F" uniqKey="Bachelot F" first="F." last="Bachelot">F. Bachelot</name></author><author><name sortKey="Dermaille, A" sort="Dermaille, A" uniqKey="Dermaille A" first="A." last="Dermaille">A. Dermaille</name></author><author><name sortKey="Fargeot, P" sort="Fargeot, P" uniqKey="Fargeot P" first="P." last="Fargeot">P. Fargeot</name></author><author><name sortKey="Namer, M" sort="Namer, M" uniqKey="Namer M" first="M." last="Namer">M. Namer</name></author><author><name sortKey="Pouillart, J" sort="Pouillart, J" uniqKey="Pouillart J" first="J." last="Pouillart">J. Pouillart</name></author><author><name sortKey="Serin, D" sort="Serin, D" uniqKey="Serin D" first="D." last="Serin">D. Serin</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:BBAD81F85C00A1390B8FEF52A86D2F282DFFBCDF</idno><date when="1995" year="1995">1995</date><idno type="doi">10.1016/S0936-6555(05)80807-6</idno><idno type="url">https://api.istex.fr/document/BBAD81F85C00A1390B8FEF52A86D2F282DFFBCDF/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">005831</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">005831</idno><idno type="wicri:Area/Istex/Curation">005831</idno><idno type="wicri:Area/Istex/Checkpoint">004811</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">004811</idno><idno type="wicri:doubleKey">0936-6555:1995:Williams C:multicentre:cross:over</idno><idno type="wicri:Area/Main/Merge">00CE70</idno><idno type="wicri:Area/Main/Curation">00C554</idno><idno type="wicri:Area/Main/Exploration">00C554</idno><idno type="wicri:Area/France/Extraction">000936</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Multicentre cross-over study of aminoglutethimide and trilostane in advanced postmenopausal breast cancer</title><author><name sortKey="Williams, C J" sort="Williams, C J" uniqKey="Williams C" first="C. J." last="Williams">C. J. Williams</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Royal South Hants Hospital, Southampton</wicri:regionArea><wicri:noRegion>Southampton</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country><wicri:regionArea>Correspondence and offprint requests to: C. J. Williams, Royal South Hants Hospital, Southampton</wicri:regionArea><wicri:noRegion>Southampton</wicri:noRegion></affiliation></author><author><name sortKey="Barley, V L" sort="Barley, V L" uniqKey="Barley V" first="V. L." last="Barley">V. L. Barley</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Bristol Radiotherapy and Oncology Centre, Bristol</wicri:regionArea><wicri:noRegion>Bristol</wicri:noRegion></affiliation></author><author><name sortKey="Blackledge, G R" sort="Blackledge, G R" uniqKey="Blackledge G" first="G. R." last="Blackledge">G. R. Blackledge</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Queen Elizabeth Hospital, Birmingham</wicri:regionArea><placeName><settlement type="city">Birmingham</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Midlands de l'Ouest</region></placeName></affiliation></author><author><name sortKey="Rowland, C G" sort="Rowland, C G" uniqKey="Rowland C" first="C. G." last="Rowland">C. G. Rowland</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Royal Devon and Exeter Hospital, Exeter</wicri:regionArea><wicri:noRegion>Exeter</wicri:noRegion></affiliation></author><author><name sortKey="Tyrrell, C J" sort="Tyrrell, C J" uniqKey="Tyrrell C" first="C. J." last="Tyrrell">C. J. Tyrrell</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Freedom Fields Hospital, Plymouth</wicri:regionArea><wicri:noRegion>Plymouth</wicri:noRegion></affiliation></author><author><name sortKey="Bachelot, F" sort="Bachelot, F" uniqKey="Bachelot F" first="F." last="Bachelot">F. Bachelot</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Centre de Charlebourg, La Garenne-Colombes</wicri:regionArea><wicri:noRegion>La Garenne-Colombes</wicri:noRegion><wicri:noRegion>La Garenne-Colombes</wicri:noRegion></affiliation></author><author><name sortKey="Dermaille, A" sort="Dermaille, A" uniqKey="Dermaille A" first="A." last="Dermaille">A. Dermaille</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Centre Oscar Lambret, Lille</wicri:regionArea><placeName><region type="region">Hauts-de-France</region><region type="old region">Nord-Pas-de-Calais</region><settlement type="city">Lille</settlement></placeName></affiliation></author><author><name sortKey="Fargeot, P" sort="Fargeot, P" uniqKey="Fargeot P" first="P." last="Fargeot">P. Fargeot</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Centre Georges-Francois-Leclerc, Dijon</wicri:regionArea><placeName><region type="region">Bourgogne-Franche-Comté</region><region type="old region">Bourgogne</region><settlement type="city">Dijon</settlement></placeName></affiliation></author><author><name sortKey="Namer, M" sort="Namer, M" uniqKey="Namer M" first="M." last="Namer">M. Namer</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Centre a Laccassagne, Nice</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Nice</settlement></placeName></affiliation></author><author><name sortKey="Pouillart, J" sort="Pouillart, J" uniqKey="Pouillart J" first="J." last="Pouillart">J. Pouillart</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Institut Curie, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Serin, D" sort="Serin, D" uniqKey="Serin D" first="D." last="Serin">D. Serin</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Clinique St Catherine, Avignon</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Avignon</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Clinical Oncology</title><title level="j" type="abbrev">YCLON</title><idno type="ISSN">0936-6555</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1995">1995</date><biblScope unit="volume">7</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="87">87</biblScope><biblScope unit="page" to="92">92</biblScope></imprint><idno type="ISSN">0936-6555</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0936-6555</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adverse effects</term><term>Aminoglutethimide</term><term>Breast neoplasm</term><term>Clinical trial</term><term>Postmenopausal</term><term>Trilostane</term><term>cross-over</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Trilostane and aminoglutethimide, both given with a physiological replacement dose of hydrocortisone, were randomly allocated to 112 eligible patients with postmenopausal advanced breast cancer. Following treatment failure on either drug the patient continued with the other, if they were in a suitable clinical condition. Sixty-three patients initially received trilostane, of whom 33 subsequently received aminoglutethimide; 49 patients initially had aminoglutethimide and 14 of these then received trilostane. Both groups of patients were comparable in all respects. There was no difference in the response rate to either drug or in the average time to disease progression for the two drugs. Of the 47 patients who received both drugs, nine (19%) showed a response to both, indicating no cross-resistance. Side effects were seen to both drugs in approximately half the patients; these were mainly gastrointestinal symptoms with trilostane and rashes and drowsiness with aminoglutethimide. There was no evidence of cross-over patient susceptibility to side effects.</div></front></TEI><affiliations><list><country><li>France</li><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Bourgogne</li><li>Bourgogne-Franche-Comté</li><li>Hauts-de-France</li><li>Midlands de l'Ouest</li><li>Nord-Pas-de-Calais</li><li>Provence-Alpes-Côte d'Azur</li><li>Île-de-France</li></region><settlement><li>Avignon</li><li>Birmingham</li><li>Dijon</li><li>Lille</li><li>Nice</li><li>Paris</li></settlement></list><tree><country name="Royaume-Uni"><noRegion><name sortKey="Williams, C J" sort="Williams, C J" uniqKey="Williams C" first="C. J." last="Williams">C. J. Williams</name></noRegion><name sortKey="Barley, V L" sort="Barley, V L" uniqKey="Barley V" first="V. L." last="Barley">V. L. Barley</name><name sortKey="Blackledge, G R" sort="Blackledge, G R" uniqKey="Blackledge G" first="G. R." last="Blackledge">G. R. Blackledge</name><name sortKey="Rowland, C G" sort="Rowland, C G" uniqKey="Rowland C" first="C. G." last="Rowland">C. G. Rowland</name><name sortKey="Tyrrell, C J" sort="Tyrrell, C J" uniqKey="Tyrrell C" first="C. J." last="Tyrrell">C. J. Tyrrell</name><name sortKey="Williams, C J" sort="Williams, C J" uniqKey="Williams C" first="C. J." last="Williams">C. J. Williams</name></country><country name="France"><noRegion><name sortKey="Bachelot, F" sort="Bachelot, F" uniqKey="Bachelot F" first="F." last="Bachelot">F. Bachelot</name></noRegion><name sortKey="Dermaille, A" sort="Dermaille, A" uniqKey="Dermaille A" first="A." last="Dermaille">A. Dermaille</name><name sortKey="Fargeot, P" sort="Fargeot, P" uniqKey="Fargeot P" first="P." last="Fargeot">P. Fargeot</name><name sortKey="Namer, M" sort="Namer, M" uniqKey="Namer M" first="M." last="Namer">M. Namer</name><name sortKey="Pouillart, J" sort="Pouillart, J" uniqKey="Pouillart J" first="J." last="Pouillart">J. Pouillart</name><name sortKey="Serin, D" sort="Serin, D" uniqKey="Serin D" first="D." last="Serin">D. Serin</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000936 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000936 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= France
|étape= Analysis
|type= RBID
|clé= ISTEX:BBAD81F85C00A1390B8FEF52A86D2F282DFFBCDF
|texte= Multicentre cross-over study of aminoglutethimide and trilostane in advanced postmenopausal breast cancer
}}
| This area was generated with Dilib version V0.6.31. |  |